EMPROFEN

This brand name is authorized in Nigeria.

Active ingredients

The drug EMPROFEN contains one active pharmaceutical ingredient (API):

1	Ibuprofen UNII WK2XYI10QM - IBUPROFEN
	Ibuprofen is a propionic acid derivative NSAID that has demonstrated its efficacy by inhibition of prostaglandin synthesis. In humans ibuprofen reduces inflammatory pain, swellings and fever. Furthermore, ibuprofen reversibly inhibits platelet aggregation.
	Read more about Ibuprofen

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-0105	Suspension	Emprofen Suspension SUSP 100 mg/5 mL		24/06/2021
A11-100070	Tablet	Emprofen 200 Tablet TAB 200 mg 11000	EMPROFEN 200 TABLET IBUPROFEN A11-100070 TABLET ORAL IBUPROFEN 200MG 11000 POM EMZOR PHARMA. IND. LTD,FLOWERGATE MIXED DEVELOPMENT SCHEME.KM 1 SAGAMU/BENIN EXPRESSWAY,SAGAMU,OGUN-STATE EMZOR PHARMA. IND. LTD,FLOWERGATE MIXED DEVELOPMENT SCHEME.KM 1 SAGAMU/BENIN EXPRESSWAY,SAGAMU,OGUN-STATE NIGERIA 29/3/2021 28 MARCH, 2026	29/03/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AE01	Ibuprofen	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives
Discover more medicines within M01AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-0105, A11-100070, A4-9467